Carl Zeiss Licences Digital Pathology from Olympus
Carl Zeiss microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.
"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”
“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”
The companies are not making specific terms and conditions of the agreement public.
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
